A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT04594707 · TERMINATED
Trial details
- NCT number
- NCT04594707
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-02-10
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.